The β3-adrenergic receptor agonist mirabegron improves glucose homeostasis in obese humans
- 23 March 2020
- journal article
- research article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 130 (5), 2319-2331
- https://doi.org/10.1172/jci134892
Abstract
BACKGROUND. Beige adipose tissue is associated with improved glucose homeostasis in mice. Adipose tissue contains β3-adrenergic receptors (β3-ARs), and this study was intended to determine whether the treatment of obese, insulin-resistant humans with the β3-AR agonist mirabegron, which stimulates beige adipose formation in subcutaneous white adipose tissue (SC WAT), would induce other beneficial changes in fat and muscle and improve metabolic homeostasis. METHODS. Before and after β3-AR agonist treatment, oral glucose tolerance tests and euglycemic clamps were performed, and histochemical analysis and gene expression profiling were performed on fat and muscle biopsies. PET-CT scans quantified brown adipose tissue volume and activity, and we conducted in vitro studies with primary cultures of differentiated human adipocytes and muscle. RESULTS. The clinical effects of mirabegron treatment included improved oral glucose tolerance (P < 0.01), reduced hemoglobin A1c levels (P = 0.01), and improved insulin sensitivity (P = 0.03) and β cell function (P = 0.01). In SC WAT, mirabegron treatment stimulated lipolysis, reduced fibrotic gene expression, and increased alternatively activated macrophages. Subjects with the most SC WAT beiging showed the greatest improvement in β cell function. In skeletal muscle, mirabegron reduced triglycerides, increased the expression of PPARγ coactivator 1 α (PGC1A) (P < 0.05), and increased type I fibers (P < 0.01). Conditioned media from adipocytes treated with mirabegron stimulated muscle fiber PGC1A expression in vitro (P < 0.001). CONCLUSION. Mirabegron treatment substantially improved multiple measures of glucose homeostasis in obese, insulin-resistant humans. Since β cells and skeletal muscle do not express β3-ARs, these data suggest that the beiging of SC WAT by mirabegron reduces adipose tissue dysfunction, which enhances muscle oxidative capacity and improves β cell function. TRIAL REGISTRATION. Clinicaltrials.gov NCT02919176. FUNDING. NIH: DK112282, P30GM127211, DK 71349, and Clinical and Translational science Awards (CTSA) grant UL1TR001998.Keywords
Funding Information
- NIDDK (DK112282)
- NIDDK (DK 71349)
- NIGMS (P30GM127211)
- NCATS (UL1TR001998)
This publication has 76 references indexed in Scilit:
- Cold acclimation recruits human brown fat and increases nonshivering thermogenesisJCI Insight, 2013
- Recruited brown adipose tissue as an antiobesity agent in humansJCI Insight, 2013
- Human resistin: found in translation from mouse to manTrends in Endocrinology & Metabolism, 2011
- Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in miceJCI Insight, 2011
- Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectinNature Medicine, 2010
- Weight loss and lipolysis promote a dynamic immune response in murine adipose tissueJCI Insight, 2010
- Association of Scavenger Receptors in Adipose Tissue With Insulin Resistance in Nondiabetic HumansArteriosclerosis, Thrombosis, and Vascular Biology, 2009
- Cold-Activated Brown Adipose Tissue in Healthy MenThe New England Journal of Medicine, 2009
- Identification and Importance of Brown Adipose Tissue in Adult HumansThe New England Journal of Medicine, 2009
- Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibresNature, 2002